Cronos Group Inc. (CRON) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
111 PETER STREET TORONTO, ON M5V 2H1 |
| State of Incorp. | ON |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 839,561 | 840,938 | 836,430 | 877,721 | 888,748 | 944,895 | |||
| Cash and cash equivalents | 571,656 | 409,428 | 413,667 | 764,644 | 633,296 | 789,543 | |||
| Short-term investments | 267,905 | 431,510 | 422,763 | 113,077 | 255,452 | 155,352 | |||
| Receivables | 37,317 | 31,866 | 27,474 | 37,810 | 31,573 | 29,163 | |||
| Inventory, net of allowances, customer advances and progress billings | 35,847 | 45,190 | 44,268 | 37,559 | 34,094 | 39,842 | |||
| Inventory | 35,847 | 45,190 | 44,268 | 37,559 | 34,094 | 39,842 | |||
| Other undisclosed current assets | 5,656 | 6,780 | 7,967 | 7,066 | 8,896 | 12,150 | |||
| Total current assets: | 918,381 | 924,774 | 916,139 | 960,156 | 963,311 | 1,026,050 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,417 | 1,571 | 2,038 | 2,273 | 5,103 | 6,113 | |||
| Property, plant and equipment | 55,604 | 57,695 | 59,785 | 60,557 | 60,582 | 66,316 | |||
| Long-term investments and receivables | 148,702 | 156,651 | 153,197 | 162,093 | 185,855 | 208,836 | |||
| Long-term investments | 80,401 | 85,571 | 81,146 | 89,748 | 113,791 | 130,400 | |||
| Accounts and financing receivable, after allowance for credit loss | 68,301 | 71,080 | 72,051 | 72,345 | 72,064 | 78,436 | |||
| Intangible assets, net (including goodwill) | 25,267 | 26,519 | 26,933 | 27,737 | 22,440 | 24,809 | |||
| Goodwill | 1,031 | 1,057 | 1,036 | 1,033 | 1,012 | 1,087 | |||
| Intangible assets, net (excluding goodwill) | 24,236 | 25,462 | 25,897 | 26,704 | 21,428 | 23,722 | |||
| Deferred income tax assets | 741 | 1,137 | |||||||
| Other noncurrent assets | 1,483 | 193 | 168 | 89 | |||||
| Total noncurrent assets: | 231,731 | 243,573 | 243,436 | 252,853 | 274,148 | 306,163 | |||
| TOTAL ASSETS: | 1,150,112 | 1,168,347 | 1,159,575 | 1,213,009 | 1,237,459 | 1,332,213 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 28,617 | 25,913 | 27,174 | 33,431 | 35,618 | 36,354 | |||
| Accounts payable | 4,749 | 9,340 | 12,842 | 11,163 | 9,989 | 12,449 | |||
| Accrued liabilities | 23,868 | 16,573 | 14,332 | 22,268 | 25,629 | 23,905 | |||
| Derivative instruments and hedges, liabilities | 29 | 37 | 80 | 15 | 73 | 574 | |||
| Due to related parties | ✕ | ✕ | ✕ | 375 | 384 | 379 | |||
| Other liabilities | 354 | 364 | |||||||
| Other undisclosed current liabilities | 1,584 | 1,612 | 1,502 | 34,286 | 1,900 | 2,267 | |||
| Total current liabilities: | 30,584 | 27,926 | 29,131 | 68,116 | 37,970 | 39,195 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 4,994 | 6,653 | |||||||
| Liabilities, other than long-term debt | 2,763 | 3,748 | 4,044 | 3,929 | 3,263 | 1,402 | |||
| Deferred income tax liabilities | 675 | 378 | 1,917 | 46 | |||||
| Due to related parties | ✕ | ✕ | ✕ | 1,370 | 1,383 | 1,346 | 1,356 | ||
| Other liabilities | 1,009 | 1,023 | |||||||
| Operating lease, liability | 1,754 | 2,050 | 2,296 | 2,546 | 4,994 | 6,653 | |||
| Total noncurrent liabilities: | 2,763 | 3,748 | 4,044 | 3,929 | 8,257 | 8,055 | |||
| Total liabilities: | 33,347 | 31,674 | 33,175 | 72,045 | 46,227 | 47,250 | |||
| Equity | |||||||||
| Equity, attributable to parent | 1,119,822 | 1,139,689 | 1,129,329 | 1,143,885 | 1,194,137 | 1,288,069 | |||
| Common stock | 613,290 | 613,152 | 612,235 | 611,318 | 605,229 | 604,626 | |||
| Additional paid in capital | 47,133 | 45,317 | 44,044 | 42,682 | 38,322 | 35,198 | |||
| Accumulated other comprehensive income (loss) | (2,110) | 18,067 | 1,537 | (797) | (18,980) | 41,688 | |||
| Retained earnings | 461,509 | 463,153 | 471,513 | 490,682 | 569,566 | 606,557 | |||
| Equity, attributable to noncontrolling interest | (3,057) | (3,016) | (2,929) | (2,921) | (2,905) | (3,106) | |||
| Total equity: | 1,116,765 | 1,136,673 | 1,126,400 | 1,140,964 | 1,191,232 | 1,284,963 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,150,112 | 1,168,347 | 1,159,575 | 1,213,009 | 1,237,459 | 1,332,213 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 24,810 | 19,021 | 20,144 | 22,887 | 20,923 | 23,061 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (9,818) | (6,777) | (7,059) | (7,025) | (5,661) | (5,493) | ||
| Other undisclosed gross profit | (11,022) | (9,145) | (10,705) | (16,096) | (14,105) | (13,448) | ||
| Gross profit: | 3,970 | 3,099 | 2,380 | (234) | 1,157 | 4,120 | ||
| Operating expenses | (25,745) | (23,719) | (24,376) | (29,485) | (32,161) | (32,186) | ||
| Operating loss: | (21,775) | (20,620) | (21,996) | (29,719) | (31,004) | (28,066) | ||
| Nonoperating income (expense) | 18,931 | 14,777 | 1,303 | (17,135) | (3,764) | 7,420 | ||
| Investment income, nonoperating | 8 | 43 | (65) | 22,406 | 375 | 3,410 | ||
| Gain (loss), foreign currency transaction, before tax | 8,816 | (3,174) | (1,643) | 51 | 2,387 | (2,852) | ||
| Other nonoperating income (expense) | 966 | (26) | 85 | 63 | (693) | 2 | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (13) | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (2,844) | (5,843) | (20,693) | (46,867) | (34,768) | (20,646) | ||
| Income from equity method investments | 3,114 | |||||||
| Other undisclosed loss from continuing operations before income taxes | (3,101) | |||||||
| Loss from continuing operations before income taxes: | (2,844) | (5,843) | (20,693) | (46,854) | (34,768) | (20,646) | ||
| Income tax expense (benefit) | 1,254 | 180 | 1,436 | (32,003) | (2,118) | 308 | ||
| Loss from continuing operations: | (1,590) | (5,663) | (19,257) | (78,857) | (36,886) | (20,338) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | (36,886) | (20,338) | |
| Income (loss) from discontinued operations | (182) | (2,834) | ||||||
| Net loss: | (1,772) | (8,497) | (19,257) | (78,857) | (36,886) | (20,338) | ||
| Net income (loss) attributable to noncontrolling interest | 128 | 137 | 88 | (105) | 117 | |||
| Other undisclosed net loss attributable to parent | (27) | |||||||
| Net loss available to common stockholders, diluted: | (1,644) | (8,360) | (19,169) | (78,884) | (36,991) | (20,221) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (1,772) | (8,497) | (19,257) | (78,857) | (36,886) | (20,338) | ||
| Other undisclosed comprehensive income (loss) | (20,090) | 16,580 | 2,414 | 18,140 | (60,572) | (24,161) | ||
| Comprehensive income (loss): | (21,862) | 8,083 | (16,843) | (60,717) | (97,458) | (44,499) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 41 | 87 | 8 | 16 | (201) | (122) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (21,821) | 8,170 | (16,835) | (60,701) | (97,659) | (44,621) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.